Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2011 2
2012 1
2013 4
2016 3
2017 4
2018 6
2019 5
2020 6
2021 12
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Witlox WJA, Grimm SE, Riemsma R, Armstrong N, Ryder S, Duffy S, Carrera VH, Posadzki P, Worthy G, Pouwels XGLV, Ramaekers BLT, Kleijnen J, Joore MA, van Asselt ADI. Witlox WJA, et al. Among authors: ramaekers blt. Pharmacoeconomics. 2021 Feb;39(2):171-180. doi: 10.1007/s40273-020-00971-x. Epub 2020 Nov 4. Pharmacoeconomics. 2021. PMID: 33145711 Free PMC article. Review.
Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Grimm SE, Fayter D, Ramaekers BLT, Petersohn S, Riemsma R, Armstrong N, Pouwels X, Witlox W, Noake C, Worthy G, Kleijnen J, Joore MA. Grimm SE, et al. Among authors: ramaekers blt. Pharmacoeconomics. 2019 Oct;37(10):1195-1207. doi: 10.1007/s40273-019-00792-7. Pharmacoeconomics. 2019. PMID: 30895564 Free PMC article. Review.
Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement.
De Ruysscher D, Defraene G, Ramaekers BLT, Lambin P, Briers E, Stobart H, Ward T, Bentzen SM, Van Staa T, Azria D, Rosenstein B, Kerns S, West C. De Ruysscher D, et al. Among authors: ramaekers blt. Radiother Oncol. 2016 Dec;121(3):440-446. doi: 10.1016/j.radonc.2016.11.003. Epub 2016 Dec 12. Radiother Oncol. 2016. PMID: 27979370 Free PMC article. Review.
Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal.
Ramaekers BLT, Riemsma R, Tomini F, van Asselt T, Deshpande S, Duffy S, Armstrong N, Severens JL, Kleijnen J, Joore MA. Ramaekers BLT, et al. Pharmacoeconomics. 2017 Feb;35(2):191-202. doi: 10.1007/s40273-016-0445-5. Pharmacoeconomics. 2017. PMID: 27566699 Free PMC article. Review.
46 results